Pharmacokinetics of Lithium: Elimination Half-Time, Renal Clearance and Apparent Volume of Distribution in Schizophrenia

SummaryThe elimination half-time and renal clearance of lithium was measured in 12 schizophrenic patients. Minimum plasma lithium concentrations during alternate dosage intervals in 5 patients increased rapidly during the first 2 to 3 days of treatment and reached a steady state level after 5 to 6 days. After the establishment of the remaining 7 patients on lithium the decline in plasma lithium concentration when treatment was stopped was monoexponenlial. Elimination half-times ranged from 19.3 to 41.3 hours (mean ± SD = 28.9 ± 7.9h) and were significantly correlated with renal creatinine clearance (p < 0.01). Renal lithium clearances ranged from 13.5 to 36.8ml/min (mean ± SD = 24.4 ± 8.0ml/min) and the apparent volumes of distribution ranged from 0.39 to 1.39L/kg (mean ± SD = 0.79 ± 0.34L/kg). There was no evidence that the elimination parameters of lithium in schizophrenic patients were significantly different from those in healthy individuals or manic-depressive patients.

[1]  M. Schou,et al.  THE TREATMENT OF MANIC PSYCHOSES BY THE ADMINISTRATION OF LITHIUM SALTS , 1954, Journal of neurology, neurosurgery, and psychiatry.

[2]  A Amdisen,et al.  Serum Level Monitoring and Clinical Pharmacokinetics of Lithium , 1977, Clinical pharmacokinetics.

[3]  F. Goodwin,et al.  Lithium ion retention and distribution. Patterns during acute mania and normothymia. , 1968, Archives of general psychiatry.

[4]  P. Grof,et al.  On the determination of lithium in blood and urine. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[5]  G. Sedvall,et al.  PHARMACOKINETICS OF LITHIUM IN MANIC‐DEPRESSIVE PATIENTS , 1973, Acta psychiatrica Scandinavica.

[6]  S. Gershon,et al.  A Controlled Study of Lithium vs. Chlorpromazine in Acute Schizophrenics , 1971, British Journal of Psychiatry.

[7]  A. Amdisen Monitoring of lithium treatment through determination of lithium concentration. , 1975, Danish medical bulletin.

[8]  J. Small,et al.  A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. , 1975, The American journal of psychiatry.

[9]  R. Morris,et al.  The excretion and retention of ingested lithium and its effect on the ionic balance of man. , 1955, The Medical journal of Australia.